tiprankstipranks
Trending News
More News >
Molecular Partners AG (MLLCF)
OTHER OTC:MLLCF
Advertisement

Molecular Partners AG (MLLCF) Similar Stocks

Compare
11 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners AG
$3.50
$151.80M
-22.22%
1 Buy
1 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.86
CHF967.86M
222.08%
1 Buy
2 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF14.06
CHF264.68M
11.07
62.90%
0 Buy
0 Hold
0 Sell
Hold
Santhera Pharmaceuticals Holding
CHF9.90
$130.55M
2.58
9.39%
1 Buy
0 Hold
0 Sell
Moderate Buy
RELIEF THERAPEUTICS Holding
CHF2.80
CHF33.79M
-50.64%
0 Buy
0 Hold
0 Sell
Hold
Xlife Sciences Ltd.
CHF19.90
CHF114.77M
3.69
-27.64%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MLLCF
Molecular Partners AG
3.50
-1.00
-22.22%
CH:IDIA
Idorsia Ltd
3.86
2.66
221.67%
CH:NWRN
Newron Pharmaceuticals SpA
13.26
5.37
68.06%
CH:SANN
Santhera Pharmaceuticals Holding
9.90
0.85
9.39%
CH:RLF
RELIEF THERAPEUTICS Holding
2.69
-2.52
-48.37%
CH:XLS
Xlife Sciences Ltd.
19.90
-7.60
-27.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis